Drug and Alcohol Abuse Treatment and Prevention Improvement Act of 1990

Summary

Drug Abuse Treatment and Prevention Improvement Act of 1990 - Title I: Improvement and Expansion of Grant Programs - Establishes in the Alcohol, Drug Abuse, and Mental Health Administration (ADAMHA) the Office for Treatment Improvement (Treatment Office) to: (1) collaborate with the Director of the Office for Substance Abuse Prevention and the Director of the National Institute on Drug Abuse (NIDA); (2) evaluate State plans and carry out programs under existing provisions; (3) train providers of prehospital emergency medical services; (4) conduct or support described programs; and (5) take other actions with regard to treatment. Authorizes appropriations. Transfers authority from the Administrator of ADAMHA to the Director of the Treatment Office for an existing grant program for reduction of the waiting period for drug abuse treatment. Removes provisions prohibiting more than one grant for any treatment program. Allows a grantee to spend not more than 50 percent of the grant for follow-up services. Increases the authorization of appropriations. Sets forth reporting requirements. Revises requirements and other matters relating to an existing program regarding drug and alcohol abuse model projects for pregnant and postpartum women and their infants. Authorizes appropriations. Transfers authority from the Administrator of ADAMHA to the Director of NIDA to make grants for drug abuse demonstration projects of national significance. Requires the Director of the Treatment Office to establish programs to provide grants to: (1) eligible institutions to provide training services to increase the supply of drug treatment professionals; (2) public and nonprofit private entities that provide drug treatment services to individuals under criminal justice supervision; and (3) hospitals, community health centers, and other appropriate entities that serve nonmetropolitan areas to assist in developing and implementing projects that provide, or expand the availability of, substance abuse treatment services. Authorizes appropriations. Directs the Secretary of Health and Human Services to make grants: (1) for the establishment of model residential projects for alcohol and drug abusing women and their children; (2) for the establishment, within the national capital area, of a model program for comprehensive treatment services for drug abuse; and (3) to community coalitions for substance abuse services. Authorizes appropriations. Directs the Secretary to establish a National Substance Abuse Prevention Training Program. Authorizes appropriations. Title II: Revision of the ADAMHA Block Grant Program - Authorizes appropriations for the Alcohol and Drug Abuse and Mental Health Services Block Grant program. Revises the Block Grant formula. Provides for the use of allotments by States for: (1) inpatient hospital drug treatment services pursuant to a contractual arrangement with a hospital if certain conditions are met; (2) counseling to family members of drug abusers; and (3) treatment programs for substance abusers in State and local criminal and juvenile justice systems. Requires States to develop and submit to the Secretary annually for review and approval a statewide Substance Abuse Treatment Plan. Requires the Director of the Treatment Office to establish a model State treatment plan. Directs the Secretary to issue guidelines for plans. Title III: Pharmacotherapy Development - Pharmacotherapy Development Act of 1990 - Part A: Federal Medication Development Program - Amends the Public Health Service Act to establish in NIDA a Medications Development Division (MDD) to: (1) work with the Commissioner of Food and Drugs to set new guidelines for the safety and efficacy trials of medications to treat drug addiction and to discuss other measures to facilitate the approval process of drug addiction treatments; (2) promote expanded research programs and studies into the development of medications to treat drug addiction; (3) track the activities of the National Institutes of Health relating to the development and use of pharmacotherapeutic treatments for drug addiction; and (4) take other specified measures to improve pharmacotherapeutic treatment of drug addiction. Establishes reporting requirements by the Director of MDD. Requires the Director of National Drug Control Policy to incorporate reports submitted under this Act into the National Drug Control Strategy. Requires the Director of MDD to provide for proper scientific review of all research grants, cooperative agreements, and contracts over which the Director has authority. Authorizes appropriations. Part B: Private Sector Development of Pharmacotherapeutics - Amends the Federal Food, Drug, and Cosmetic Act to establish procedures for the investigation and designation of drugs for the treatment of addictions to illegal drugs. Authorizes appropriations. Part C: Medications Review Process Reform - Authorizes the Secretary to permit: (1) an entity submitting an investigational new drug application or protocol for medications to treat drug addiction to provide information required by the Secretary as it becomes available; and (2) parallel track trials to be used for medications to treat drug addiction. Part D: High Priority Research Areas - Expresses the sense of the Congress that MDD shall devote special attention and resources to achieving the development of a methadone alternative, a long-acting narcotic antagonist, a cocaine blocking treatment, a cocaine-blocker/narcotic antagonist treatment, medications to treat addictions to methamphetamine, and medications to treat pregnant addicts and their fetuses. Part E: Report by the Surgeon General - Requires: (1) the Director of MDD to establish a panel of independent experts in the field of pharmacotherapeutic treatment of drug addiction to assess the national strategy for developing such treatments and make appropriate recommendations; and (2) the Surgeon General of the United States to submit to the appropriate congressional committees a report setting forth recommendations of such panel and assessing the progress of the Nation toward development of safe, efficacious pharmacological treatments for drug addiction. Title IV: Miscellaneous Provisions - Directs the Secretary to: (1) conduct a study concerning the relationship between an individual's receptivity to use or consume legal drugs and that individual's use or consumption of illegal drugs, including the effect of advertising and marketing campaigns that promote the use of legal drugs on the public; and (2) submit a report to specified congressional committees on the results of the study. Amends the Omnibus Crime Control and Safe Streets Act of 1986 to require at least 20 percent of amounts appropriated for Justice System Improvement grants to be used for drug treatment programs in the criminal justice system, giving priority to programs that provide referrals to community treatment programs for individuals soon to be released from incarceration and treatment services for juvenile and female offenders. Amends the Drug-Free Schools and Communities Act of 1986 to authorize appropriations of $1,200,000,000 (currently, such sums as necessary) for FY 1990 through 1993 for drug abuse education and prevention programs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

4 official files

• Reported to Senate (text)

  Reported to Senate · EN

  ViewDownloadOpen at official source

• Introduced in Senate (text)

  Introduced in Senate · EN

  ViewDownloadOpen at official source

• Reported to Senate with amendment(s)

  summary · EN · 27 September 1990

  Open at official source

• Introduced in Senate

  summary · EN · 17 May 1990

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.